MYC primes a paralog synthetic lethality involving the mitochondrial translocase subunits TIMM17A and TIMM17B and N-Acetylaspartate

To identify the genes and pathways required for the survival of MYC -amplified cancers, we engineered an isogenic cell system in which transformation is driven by oncogenic MYC . Using a genome-scale CRISPR-Cas9 library, we identified the mitochondrial membrane translocase TIMM17A as uniquely essential for the survival of MYC-transformed cells. This dependency arises from MYC-driven suppression of TIMM17B , the paralog of TIMM17A . TIMM17A/B is an essential component of the TIM23 mitochondrial protein import complex, and the MYC-induced suppression of TIMM17B creates a strong dependency on TIMM17A . N-acetylaspartate supplementation rescued TIMM17A dependency in MYC -amplified cell lines, highlighting the unique and crucial role of this metabolite in the cell fitness of MYC -amplified cancers. These observations identify a paralog dependency required for the survival of a subset of MYC-driven cancers.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-11-06
DOI
https://doi.org/10.1126/sciadv.aej2662
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

MYC primes a paralog synthetic lethality involving the mitochondrial translocase subunits TIMM17A and TIMM17B and N-Acetylaspartate

Lucas Dailey, Federica Piccioni, Kathia E. Rodarte, Brian H. Shim et al.
1 links
Science Advances
Mitochondrial Function and Pathology
article

MYC primes a paralog synthetic lethality involving the mitochondrial translocase subunits TIMM17A and TIMM17B and N-Acetylaspartate

Lucas Dailey, Federica Piccioni, Kathia E. Rodarte, Brian H. Shim, Hans R. Widlund, Jessica A. Talamas, Sydney M. Moyer, Jonathan So, Jonathan P. Rennhack, Clary B. Clish, William C. Hahn, Nika N. Danial, Sydney Gang, David E. Root, Joseph D. DeAngelo, Gaia Taig, John Ryan Jacob, Nina Ilić, Jasmine Stavridi, Helen Wang, Andrea Jiang, Melis A. Akinci, Sehyun Oh
article en

Abstract

To identify the genes and pathways required for the survival of MYC -amplified cancers, we engineered an isogenic cell system in which transformation is driven by oncogenic MYC . Using a genome-scale CRISPR-Cas9 library, we identified the mitochondrial membrane translocase TIMM17A as uniquely essential for the survival of MYC-transformed cells. This dependency arises from MYC-driven suppression of TIMM17B , the paralog of TIMM17A . TIMM17A/B is an essential component of the TIM23 mitochondrial protein import complex, and the MYC-induced suppression of TIMM17B creates a strong dependency on TIMM17A . N-acetylaspartate supplementation rescued TIMM17A dependency in MYC -amplified cell lines, highlighting the unique and crucial role of this metabolite in the cell fitness of MYC -amplified cancers. These observations identify a paralog dependency required for the survival of a subset of MYC-driven cancers.

Science AdvancesVol. 12(45)
Broad Institute (US), Brigham and Women's Hospital (US), Harvard University (US), Dana-Farber Cancer Institute (US)
National Cancer Center, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 27%
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon